Pathology and Lab Medicine - Clinical Practice - Global Oncology Academy

Episodes 1-15 of 15

- Federico Cappuzzo
  Peer
- Professor Solange Peters
  Peer
- Professor Yi-Long Wu
  Peer
0
CME/CE
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
0.25 credits
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global A...
0.25 credits
- Peter Schmid, FRCP, MD, PhD
  Peer
- Javier Cortes, MD, PhD
  Peer
2
CME/CE
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
- Jeffrey S. Weber, MD, PhD
  Peer
5
CME/CE
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
0.25 credits
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Pat...
0.25 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
7
CME/CE
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and T...
0.50 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
9
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Ca...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
7
CME/CE
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
18
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
4
CME/CE
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Tr...
0.50 credits
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
- Kai He, MD, PhD
  Peer
- Jyoti D. Patel, MD, FASCO
  Peer
4
CME/CE
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Lessons
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Lessons
0.25 credits
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Globa...
0.25 credits
- D. Ross Camidge, MD, PhD
  Peer
- Luis Paz-Ares, MD, PhD
  Peer
4
CME/CE
Acquired Resistance to Targeted Therapy of NSCLC: A Global Perspective
Acquired Resistance to Targeted Therapy of NSCLC: A Global Perspective
0.25 credits
Acquired Resistance to Targeted Therapy of NSCLC: A Global Perspective
0.25 credits
- Everett E. Vokes, MD
  Peer
- D. Ross Camidge, MD, PhD
  Peer
4
CME/CE
The Changing Landscape of NSCLC: MET Inhibitors
The Changing Landscape of NSCLC: MET Inhibitors
0.25 credits
The Changing Landscape of NSCLC: MET Inhibitors
0.25 credits
- Mark A. Socinski, MD
  Peer
- Ming-Sound Tsao, MD, FRCPC
  Peer
8
CME/CE
How to Approach Liquid Biopsy in the Treatment of NSCLC
How to Approach Liquid Biopsy in the Treatment of NSCLC
0.25 credits
How to Approach Liquid Biopsy in the Treatment of NSCLC
0.25 credits
- John J. Russell, MD
  Peer
- Meredith Wadman, BM, BCh, M.S.
  Peer
6
Book Club
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
- Matt Birnholz, MD
  Peer
11
Project Oncology®
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
- Ana Maria Rosario
  Peer
18
Clinician's Roundtable
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis

Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer

Javier Cortes, MD, PhD

Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer

Learn More

Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer

UP NEXT...

Components to a Comprehensive Lung Cancer Screening Program

Guest
Jacob Sands, MD